rs878854386

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.

The NM_001849.4(COL6A2):​c.1358G>A​(p.Arg453His) variant causes a missense change. The variant allele was found at a frequency of 0.000075 in 1,479,442 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R453C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000079 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000075 ( 0 hom. )

Consequence

COL6A2
NM_001849.4 missense

Scores

3
13
3

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:1

Conservation

PhyloP100: 5.69

Publications

3 publications found
Variant links:
Genes affected
COL6A2 (HGNC:2212): (collagen type VI alpha 2 chain) This gene encodes one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The product of this gene contains several domains similar to von Willebrand Factor type A domains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in this gene are associated with Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. Three transcript variants have been identified for this gene. [provided by RefSeq, Jul 2008]
COL6A2 Gene-Disease associations (from GenCC):
  • collagen 6-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
  • Ullrich congenital muscular dystrophy 1B
    Inheritance: AR, AD Classification: DEFINITIVE Submitted by: G2P
  • Bethlem myopathy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp
  • Ullrich congenital muscular dystrophy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Bethlem myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ullrich congenital muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myosclerosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL6A2NM_001849.4 linkc.1358G>A p.Arg453His missense_variant Exon 16 of 28 ENST00000300527.9 NP_001840.3
COL6A2NM_058174.3 linkc.1358G>A p.Arg453His missense_variant Exon 16 of 28 ENST00000397763.6 NP_478054.2
COL6A2NM_058175.3 linkc.1358G>A p.Arg453His missense_variant Exon 16 of 28 NP_478055.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL6A2ENST00000300527.9 linkc.1358G>A p.Arg453His missense_variant Exon 16 of 28 1 NM_001849.4 ENSP00000300527.4
COL6A2ENST00000397763.6 linkc.1358G>A p.Arg453His missense_variant Exon 16 of 28 5 NM_058174.3 ENSP00000380870.1
COL6A2ENST00000409416.6 linkc.1358G>A p.Arg453His missense_variant Exon 15 of 27 5 ENSP00000387115.1
COL6A2ENST00000413758.1 linkc.-20G>A upstream_gene_variant 3 ENSP00000395751.1

Frequencies

GnomAD3 genomes
AF:
0.0000789
AC:
12
AN:
152130
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000803
AC:
7
AN:
87126
AF XY:
0.000133
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000386
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000909
Gnomad OTH exome
AF:
0.000425
GnomAD4 exome
AF:
0.0000746
AC:
99
AN:
1327312
Hom.:
0
Cov.:
32
AF XY:
0.0000769
AC XY:
50
AN XY:
650282
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
28284
American (AMR)
AF:
0.00
AC:
0
AN:
21644
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
20362
East Asian (EAS)
AF:
0.000117
AC:
4
AN:
34234
South Asian (SAS)
AF:
0.0000438
AC:
3
AN:
68528
European-Finnish (FIN)
AF:
0.0000439
AC:
2
AN:
45568
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5110
European-Non Finnish (NFE)
AF:
0.0000820
AC:
86
AN:
1049060
Other (OTH)
AF:
0.0000734
AC:
4
AN:
54522
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000789
AC:
12
AN:
152130
Hom.:
0
Cov.:
34
AF XY:
0.000108
AC XY:
8
AN XY:
74320
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41434
American (AMR)
AF:
0.00
AC:
0
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000162
AC:
11
AN:
67990
Other (OTH)
AF:
0.00
AC:
0
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000219
Hom.:
0
Bravo
AF:
0.0000491

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:4
Jun 26, 2019
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 07, 2017
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

COL6A2: PP3 -

Sep 04, 2015
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The R453H variant has not beenpublished as a pathogenic variant, nor has it been reported as a benign polymorphism to our knowledge. It was notobserved in approximately 5,500 individuals of European and African American ancestry in the NHLBI ExomeSequencing Project, indicating it is not a common benign variant in these populations. The R453H variant is aconservative amino acid substitution, which is not likely to impact secondary protein structure as theseresidues share similar properties. However, this substitution occurs at a position that is conserved acrossspecies, and in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging tothe protein structure/function. -

not specified Uncertain:1
Dec 01, 2015
Center for Genetic Medicine Research, Children's National Medical Center
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

Bethlem myopathy 1A Benign:1
Jan 14, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.47
BayesDel_addAF
Uncertain
0.016
T
BayesDel_noAF
Uncertain
0.11
CADD
Pathogenic
32
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.64
D;.;.;.
Eigen
Uncertain
0.60
Eigen_PC
Uncertain
0.54
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.95
D;T;.;D
M_CAP
Pathogenic
0.71
D
MetaRNN
Uncertain
0.66
D;D;D;D
MetaSVM
Pathogenic
0.88
D
MutationAssessor
Benign
1.3
L;L;L;L
PhyloP100
5.7
PrimateAI
Uncertain
0.74
T
PROVEAN
Benign
-1.9
N;N;N;N
REVEL
Pathogenic
0.71
Sift
Uncertain
0.025
D;D;D;D
Sift4G
Uncertain
0.045
D;T;T;T
Polyphen
1.0
D;D;D;D
Vest4
0.41
MutPred
0.48
Loss of methylation at R453 (P = 0.0062);Loss of methylation at R453 (P = 0.0062);Loss of methylation at R453 (P = 0.0062);Loss of methylation at R453 (P = 0.0062);
MVP
0.98
MPC
0.68
ClinPred
0.38
T
GERP RS
4.4
PromoterAI
-0.026
Neutral
Varity_R
0.15
gMVP
0.48
Mutation Taster
=48/52
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs878854386; hg19: chr21-47540454; API